ROCHE - MS DISEASE

TitleROCHE - MS DISEASE
BrandROCHE
Product/ServiceAWARNESS OF MS DISEASE AND THE IMPORTANCE OF CORRECT TREATMENT
Category D02. Interactive Video
Entrant MILTTON Helsinki, FINLAND
Idea Creation MILTTON Helsinki, FINLAND
Production OTTO PRODUCTION Helsinki, FINLAND
Additional Company EVERMADE Helsinki, FINLAND
Credits
Name Company Position
Erkko Mannila Miltton Creative Creative Director
Roope Sandberg Miltton Creative Art Director
Ella Antila Miltton Creative Art Director
Eija Anteroinen Miltton Creative Account Director
Inka Kosonen Miltton Creative Agency Producer
Tuomas Velling Evermade Lead Developer
Sauli Puukangas Evermade Designer
Joakim Larres Evermade Project Manager
Pekka Harala Otto Production Director
Niels Thastum Otto Production Director Of Photography
Ari Laitinen Otto Production Producer
Anthony Bentley Otto Production Editor
Anné Kulonen Otto Production Composer
Timo Anttila Otto Production Sound Designer
Timo Luomanen Otto Production Colorist
Milan Gromilic Otto Production Choreographer
Aljosa Spajic Otto Production Production Designer
Jelena Djordevic Otto Production Costume designer
Natasa Krstic Otto Production Make up and hair

Background

• Situation – Roche has launched a new very effective drug to treat and even reduce or postpone symptoms in MS-disease. • Brief – How can we build awareness in various treatment of the MS-disease, when we can’t name a drug? How can we show that the patient has choices in treatments that might postpone symptoms and even give several years of symptomless life? • Objectives – To build awareness on the MS-disease. In long term empower patients to ask tough questions about different treatments (and drugs) available. To give realistic insight generally to the life with MS-disease and how different life might go in different treatments.

Describe the strategy

Data gathering – background data of MS-disease and it’s different forms. The political information gathered by questionary to the decision makers of drug reimbursements and of the right of equal and efficient treatment to every patient. Target audience (consumer demographic / individuals / organisations) – The disease infects mostly young people (a bit more young women about 20-25 y), but we wanted to reach general public, because MS effects the patient all the lives on close ones. Also the right for equal treatment is affecting all the serious illnesses e.g. cancer. The campaign was done in close co-operation with patient groups and Finnish Neuro Society. Relevance to platform – film form was the best way to show the two different destinies from diagnose to life during treatments. Also emphasis in digital pushed also the new MS-information site. Approach – 1. Building emotion via film, 2. Information and other content

Describe the execution

• Implementation – cinema campaign, PR, digital native campaign, Patient societies and Neuro Society longterm banners and the study among political decision makers • Timeline - from May 29.5.2019 trough July the 24th 2019 • Placement - film in Cinema, interactive film on website, PR in the city of Pori in Finland and in Helsinki during the International MS-Day 29th of May. • Scale – Medium and long term, the campaign continues until 29th of May in 2020

List the results

• Reach cinema campaign /national/ 2 weeks 172 000 viewers, native digital campaign 25-45 y/w 75 000 uniq visitors CTR 0,64 (average in health care 0,48) • Engagement – In July PR event for 5 days, during which 1400 people felt how the everyday feels for MS-patient • Sales – no sales KPI’s • Achievement against business targets – there was none business targets